Downloads

Clinical Trials

More than $45 million was spent developing Vital 3 for people with joint pain. Prominent rheumatologists with major university affiliations ran safety, pilot, dosing, and efficacy studies, following the FDA's Good Clinical Practice Guidelines. If you're interested in reading the details of some of the human clinical trials that studied Vital 3, we encourage you to download the following journal articles by clicking on the PDF links below:

Participants in this study reported a reduced number of swollen and tender (painful) joints with the use of Vital 3:

Trentham DE, Dynesius-Trentham RA, Orav EJ, et al. Effects of oral administration of type II collagen on rheumatoid arthritis. Science 1993; 261:1727–1730.

This large study followed 274 patients with active Rheumatoid Arthritis: Barnett ML; Kremer JM; St. Clair W, et al. Treatment of rheumatoid arthritis with oral type II collagen. Results of a multicenter, double-blind, placebo-controlled trial. Arthritis and Rheumatism 1998 Feb; 41 (2):290–297.

Success was shown when 10 patients with active Juvenile Rheumatoid Arthritis were treated with Vital 3 for 12 weeks:

Barnett ML, Combitchi D, Trentham DE. A pilot trial of oral type II collagen in the treatment of juvenile rheumatoid arthritis. Arthritis and Rheumatism 1996 Apr; 39(4):623–628.

Is Vital 3 Right For You?

Download a PDF of the following table and print it out. Mark your current level of joint pain, morning stiffness, and mobility issues (problems moving around). After two weeks and after four weeks of trying Vital 3, mark your level of pain. Once you have finished one bottle of Vital 3 — a six-week supply — rank your levels again. We think you'll see improvement! If you don't, return the empty bottle for a full refund. There are no side effects, and no drug interactions. There is no risk!

Download the "Measure Your Progress" table